Patents by Inventor Julia Schanda

Julia Schanda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
    Publication number: 20210147415
    Abstract: The invention relates to inhibitors of the NHR2 tetramerization and their use as tumor therapeutics (e.g. against acute myeloid leukemia (AML)), cytostatics, and diagnostic agents.
    Type: Application
    Filed: November 6, 2020
    Publication date: May 20, 2021
    Inventors: Alexander Metz, Holger Gohlke, Julia Schanda, Christian Wichmann, Manuel Grez
  • INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
    Publication number: 20180230143
    Abstract: The invention relates to inhibitors of the NHR2 tetramerization and their use as tumor therapeutics (e.g. against acute myeloid leukemia (AML)), cytostatics, and diagnostic agents.
    Type: Application
    Filed: December 11, 2017
    Publication date: August 16, 2018
    Inventors: Alexander Metz, Holger Gohlke, Julia Schanda, Christian Wichmann, Manuel Grez
  • INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
    Publication number: 20160108031
    Abstract: The invention relates to inhibitors of the NHR2 tetramerization and their use as tumor therapeutics (e.g. against acute myeloid leukemia (AML)), cytostatics, and diagnostic agents.
    Type: Application
    Filed: April 25, 2014
    Publication date: April 21, 2016
    Applicant: Heinrich-Heine-Universitat Dusseldorf
    Inventors: Alexander Metz, Holger Gohlke, Julia Schanda, Christian Wichmann, Manuel Grez